Amarin Announces FDA Advisory Committee Outcome for the Use of Vascepa in the Treatment of High Triglycerides With Mixed Dyslipidemia by longitudeadmin | Oct 16, 2013 | Portfolio News
New Data Highlight Value of Corus® CAD in Reducing Unnecessary Cardiac Testing and Costs for Women with Symptoms Suggestive of Obstructive Coronary Artery Disease by longitudeadmin | Oct 10, 2013 | Portfolio News
Aptus Announces Positive Initial Data from ANCHOR Post-Market Registry by longitudeadmin | Oct 8, 2013 | Portfolio News
Amarin Announces Enrollment of the REDUCE-IT Cardiovascular Outcomes Study Surpasses 6,000 Patients by longitudeadmin | Sep 25, 2013 | Portfolio News
BioWorld Today – Dopamine Road: Civitas’ $38M To Fill in Parkinson’s ‘Potholes’ by longitudeadmin | Sep 12, 2013 | Portfolio News
